Google
 
Google

World Stem Cell Summit 2010

Wednesday, April 8, 2009

Bone Marrow Transplantation - Table of Contents alert Volume 43 Issue 7

BONE MARROW TRANSPLANTATION

April 2009 Volume 43 Number 7, pp 517 - 592
---------------------------------------------------------------------
Nature Clinical Practice Oncology is now Nature Reviews Clinical
Oncology.

Nature Reviews Clinical Oncology brings the distinguished
reputation of the Nature Reviews series into the clinical
sciences. The journal will remain dedicated to publishing the
latest advances in oncology.

For more information visit
http://links.ealert.nature.com/ctt?kn=31&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
---------------------------------------------------------------------
A combined print and online personal subscription to this journal
gives you your own print copy and access to the entire website
including all back issues. Purchasing a subscription is easy; use
our online order form at
http://links.ealert.nature.com/ctt?kn=60&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
to start your subscription today.

----------------------
REVIEW
----------------------
Cancer stem cells: relevance to SCT
T Lin, R J Jones and W Matsui
Abstract: http://links.ealert.nature.com/ctt?kn=10&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=70&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

----------------------
ORIGINAL ARTICLES
----------------------
A novel approach for quantification of KIR expression in healthy donors
and pediatric recipients of hematopoietic SCTs
X Chen, J Knowles, R C Barfield, K A Kasow, R Madden, P Woodard,
D K Srivastava, E M Horwitz, R Handgretinger and G A Hale
Abstract: http://links.ealert.nature.com/ctt?kn=43&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=6&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

Hematopoietic SCT in patients with a history of invasive fungal infection
P Zhang, A Song, Z Wang, S Feng, L Qiu and M Han
Abstract: http://links.ealert.nature.com/ctt?kn=18&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=13&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

The polymorphism IL-1[beta] T-31C is associated with a longer overall
survival in patients with multiple myeloma undergoing auto-SCT
A J Vangsted, T W Klausen, W Ruminski, P Gimsing, N F Andersen, A O Gang,
N Abildgaard, L M Knudsen, J L Nielsen, H Gregersen and U Vogel
Abstract: http://links.ealert.nature.com/ctt?kn=61&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=23&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

High-dose chemotherapy followed by stem cell rescue for high-risk germ
cell tumors: the Stanford experience
R Agarwal, C C Dvorak, K E Stockerl-Goldstein, L Johnston and S Srinivas
Abstract: http://links.ealert.nature.com/ctt?kn=20&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=3&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

A prospective randomized controlled trial comparing PCR-based and empirical
treatment with liposomal amphotericin B in patients after allo-SCT
H Hebart, L Klingspor, T Klingebiel, J Loeffler, J Tollemar, P Ljungman,
H Wandt, K Schaefer-Eckart, H J Dornbusch, C Meisner, C Engel, N Stenger,
T Mayer, O Ringden and H Einsele
Abstract: http://links.ealert.nature.com/ctt?kn=52&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=64&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

Treatment of oral mucositis after peripheral blood SCT with ATL-104
mouthwash: results from a randomized, double-blind, placebo-controlled trial
A Hunter, P Mahendra, K Wilson, P Fields, G Cook, A Peniket, C Crawley,
R Hickling and R Marcus
Abstract: http://links.ealert.nature.com/ctt?kn=16&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=45&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

Patient socioeconomic status as a prognostic factor for allo-SCT
L Silla, G B Fischer, A Paz, L E Daudt, I Mitto, B Katz, M da Graca Grossini,
H N Bittencourt, A Jochims, L Fogliatto, C M Bittar, J R Friedrisch and
R I Bittencourt
Abstract: http://links.ealert.nature.com/ctt?kn=24&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=66&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

----------------------
LETTERS TO THE EDITOR
----------------------
Dasatinib-induced restoration of donor chimerism in BCR-ABL1-positive ALL
after failure of imatinib therapy and allo-SCT
A Quintas-Cardama and J Cortes
http://links.ealert.nature.com/ctt?kn=27&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan:
a retrospective multicenter study
T Muta, T Fukuda and M Harada
http://links.ealert.nature.com/ctt?kn=65&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

High-dose therapy with autologous PBSC transplantation in the front-line
treatment of Waldenstrom's macroglobulinemia
T Caravita, A Siniscalchi, A Tendas, L Cupelli, T Dentamaro, G Natale,
A Spagnoli and P de Fabritiis
http://links.ealert.nature.com/ctt?kn=71&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

Allogeneic hematopoietic cell transplantation for t-AML following liver
transplantation from the same haploidentical donor
R Zeiser, A Zerweck, H Bertz and J Finke
http://links.ealert.nature.com/ctt?kn=58&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

Autologous or reduced-intensity conditioning allotransplantation for
de novo multiple myeloma
P Moreau
http://links.ealert.nature.com/ctt?kn=4&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0

---------------------------------------------------------------------
Transplantation Immunobiology brought to you by Immunology & Cell
Biology

Immunology & Cell Biology
http://links.ealert.nature.com/ctt?kn=28&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
presents Transplantation Immunobiology - a
limited time special issue highlighting the two greatest challenges
facing the widespread use of transplanted organs and the two approaches
used to overcome these problems. The accompanying web focus also dives
into various techniques available for preventing transplantable organ
rejection.

Explore what Transplantation Immunobiology has to offer today!
http://links.ealert.nature.com/ctt?kn=42&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0


=====================================================================

You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=22&m=32254992&r=MTc1NjE0NTQ4OQS2&b=2&j=NDcyMTAwMDES1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© Copyright 2009 Nature Publishing Group

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time